PhoenixBio Co., Ltd. (TYO:6190)
Japan · Delayed Price · Currency is JPY 300.00
-2.00 (-0.66%)
Sep 16, 2026, 3:30 PM JST
PhoenixBio Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,229 | 1,791 | 1,495 | 1,942 | 2,235 | 1,733 | |
Market Cap Growth | -28.09% | 19.82% | -23.02% | -13.12% | 28.96% | -14.45% |
Enterprise Value | 424 | 1,077 | 778 | 1,060 | 1,536 | 1,329 |
Last Close Price | 302.00 | 440.00 | 369.00 | 482.00 | 615.00 | 524.00 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 81.94 | 14.33 | - | 74.68 | 4.53 | - |
Forward PE | - | 22.99 | 22.99 | 22.99 | 22.99 | 22.99 |
PS Ratio | 0.86 | 1.14 | 0.97 | 1.13 | 1.05 | 1.31 |
PB Ratio | 0.84 | 1.15 | 1.10 | 1.08 | 1.48 | 2.09 |
P/TBV Ratio | 0.85 | 1.16 | 1.11 | 1.09 | 1.48 | 2.10 |
P/FCF Ratio | 21.95 | 31.98 | - | - | 8.28 | 173.29 |
P/OCF Ratio | 18.08 | 26.34 | - | - | 8.07 | 108.31 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.30 | 0.69 | 0.51 | 0.62 | 0.72 | 1.00 |
EV/EBITDA Ratio | - | 9.28 | - | 35.32 | 2.89 | - |
EV/EBIT Ratio | - | 12.98 | - | 211.91 | 3.02 | - |
EV/FCF Ratio | 7.57 | 19.23 | - | - | 5.69 | 132.89 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.20 | 0.31 | 0.41 | 0.40 | 0.75 | 1.25 |
Debt / EBITDA Ratio | - | 4.18 | - | 24.07 | 2.12 | - |
Debt / FCF Ratio | - | 8.66 | - | - | 4.18 | 103.70 |
Net Debt / Equity Ratio | -0.55 | -0.43 | -0.43 | -0.37 | -0.28 | -0.35 |
Net Debt / EBITDA Ratio | 1073.33 | -5.72 | 5.42 | -22.07 | -0.80 | 3.51 |
Net Debt / FCF Ratio | - | -11.84 | 6.22 | 6.02 | -1.58 | -28.80 |
Asset Turnover | 0.66 | 0.70 | 0.62 | 0.60 | 0.80 | 0.55 |
Inventory Turnover | 1.11 | 1.14 | 1.08 | 1.28 | 1.82 | 2.22 |
Quick Ratio | 3.24 | 3.44 | 2.33 | 3.80 | 1.43 | 3.54 |
Current Ratio | 4.20 | 4.41 | 3.03 | 5.06 | 1.78 | 4.23 |
Return on Equity (ROE) | 1.06% | 8.57% | -28.35% | 1.57% | 42.10% | -40.29% |
Return on Assets (ROA) | -1.02% | 2.32% | -3.40% | 0.11% | 12.01% | -4.38% |
Return on Invested Capital (ROIC) | -3.23% | 9.50% | -14.22% | 0.20% | 60.45% | -25.02% |
Return on Capital Employed (ROCE) | -2.10% | 4.60% | -7.90% | 0.20% | 29.40% | -9.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.22% | 6.98% | -29.97% | 1.34% | 22.06% | -22.33% |
FCF Yield | 4.56% | 3.13% | -6.29% | -5.67% | 12.08% | 0.58% |
Buyback Yield / Dilution | -0.48% | -0.50% | -6.95% | 25.42% | -53.57% | -2.11% |